ArticleJAMA network open2026

Darolutamide With Concomitant Lipid-Modifying Agents in Nonmetastatic Castration-Resistant Prostate Cancer.

Murilo A Luz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.